| Literature DB >> 18284676 |
James P White1, Jacob M Wilson, Krista G Austin, Beau K Greer, Noah St John, Lynn B Panton.
Abstract
PURPOSE: To determine if timing of a supplement would have an effect on muscle damage, function and soreness.Entities:
Year: 2008 PMID: 18284676 PMCID: PMC2288590 DOI: 10.1186/1550-2783-5-5
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Subject characteristics (N = 27).
| Group | Age(yr) | Height(m) | Weight(kg) | Lean Mass (kg) | % Body Fat |
| Control(n = 9) | 20.6 ± 02.1 | 1.79 ± 0.09 | 78.1 ± 11.7 | 68.2 ± 09.1 | 12.4 ± 05.2 |
| Pre (n = 9) | 21.6 ± 02.4 | 1.80 ± 0.06 | 89.5 ± 23.4 | 73.3 ± 09.0 | 15.7 ± 10.9 |
| Post (n = 9) | 21.1 ± 02.2 | 1.77 ± 0.10 | 81.3 ± 13.7 | 68.1 ± 10.0 | 15.6 ± 09.1 |
Values are means ± standard deviation. Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, received placebo before and after exercise.
Values for CK, MVC, and VAS for the three supplement groups (N = 27).
| Variables | 0 | 6 hrs | 24 hrs | 48 hrs | 72 hrs | 96 hrs | |
| CK | Control | 94 ± 63 | 153 ± 134 | 245 ± 178 | 1084 ± 1709* | 1428 ± 2208* | 1181 ± 1540* |
| (U/L) | Pre | 113 ± 031 | 184 ± 098 | 271 ± 273 | 0620 ± 1098* | 1050 ± 2189* | 0873 ± 1513* |
| (n = 9) | Post | 97 ± 28 | 139 ± 057 | 182 ± 059 | 280 ± 115* | 424 ± 286* | 634 ± 787* |
| MVC | Control | 221 ± 37 | 140 ± 21* | 137 ± 31* | 150 ± 053* | 149 ± 038* | 172 ± 051* |
| (NM) | Pre | 252 ± 66 | 198 ± 43* | 185 ± 26* | 209 ± 047* | 201 ± 049* | 231 ± 059* |
| (n = 9) | Post | 204 ± 29 | 143 ± 040* | 139 ± 046* | 140 ± 047* | 154 ± 047* | 157 ± 039* |
| VAS | Control | 0.11 ± 0.17 | 1.19 ± 1.45* | 1.84 ± 1.15* | 3.59 ± 1.56* | 2.60 ± 1.37* | 1.09 ± 1.03* |
| (cm) | Pre | 0.03 ± 0.07 | 0.66 ± 0.60* | 2.22 ± 1.28* | 3.44 ± 1.82* | 2.54 ± 1.56* | 1.48 ± 1.48* |
| (n = 9) | Post | 0.02 ± 0.04 | 0.73 ± 0.96* | 1.54 ± 1.33* | 2.12 ± 1.58* | 1.22 ± 1.03* | 0.63 ± 0.51* |
Values are means ± standard deviation.
* p < 0.05, significantly different from 0 time point
Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, received placebo before and after exercise; CK, creatine kinase; MVC, maximal voluntary contraction; NM, newton meters; VAS, visual analogue scale.
Figure 1Peak torque of maximal voluntary contraction (MVC) across the 96 hours. Values are means ± standard errors, * p < 0.05, significantly different from 0 time point, there were no differences among groups. Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, received placebo before and after exercise.
Figure 2Percent decrease of maximal voluntary contraction (MVC) across the 96 hours. Values are means ± standard errors. Values for % decrease in MVC = ((Pre – time point)/Pre) × 100. * p < 0.05, significantly different from 0 time point, there were no differences among groups. Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, received placebo before and after exercise.
Figure 3Serum creatine kinase (CK) Concentration across the 96 hours. Values are means ± standard errors. * p < 0.05, significantly different from 0 time point, there were no differences among groups. Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, received placebo before and after exercise.
Figure 4Visual analogue scale (VAS) across the 96 hours. Values are means ± standard errors. * p < 0.05, significantly different from 0 time point, there were no differences among groups. Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, received placebo before and after exercise